Security and effectivity from the dapagliflozim with other inhibitor of the SGLT-2: What decision to take?

Mejía-Zambrano H. · Semergen (2022) · DOI: 10.1016/j.semerg.2022.01.004

Instituciones: Universidad Privada San Juan Bautista